37 related articles for article (PubMed ID: 11293260)
1. Ligand selectivity hotspots in serotonin GPCRs.
Simon IA; Bjørn-Yoshimoto WE; Harpsøe K; Iliadis S; Svensson B; Jensen AA; Gloriam DE
Trends Pharmacol Sci; 2023 Dec; 44(12):978-990. PubMed ID: 37914598
[TBL] [Abstract][Full Text] [Related]
2. Development of selective agents targeting serotonin 5HT
Ostrowska K; Grzeszczuk D; Głuch-Lutwin M; Gryboś A; Siwek A; Dobrzycki Ł; Trzaskowski B
Medchemcomm; 2017 Aug; 8(8):1690-1696. PubMed ID: 30108880
[TBL] [Abstract][Full Text] [Related]
3. Effects of theaflavin-gallate
Maiti S; Banerjee A; Kanwar M
Phytomed Plus; 2022 May; 2(2):100237. PubMed ID: 35403090
[No Abstract] [Full Text] [Related]
4. Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.
Bronowska A; Chilmonczyk Z; Leś A; Edvardsen O; Ostensen R; Sylte I
J Comput Aided Mol Des; 2001 Nov; 15(11):1005-23. PubMed ID: 11989622
[TBL] [Abstract][Full Text] [Related]
5. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
[TBL] [Abstract][Full Text] [Related]
6. 8-[4-[2-(1,2,3,4-Tetrahydroisoquinolinyl]butyl-8-azaspiro[4.5]decane-7,9-dione: a new 5-HT1A receptor ligand with the same activity profile as buspirone.
Mokrosz JL; Dereń-Wesołek A; Tatarczyńska E; Duszyńska B; Bojarski AJ; Mokrosz MJ; Chojnacka-Wójcik E
J Med Chem; 1996 Mar; 39(5):1125-9. PubMed ID: 8676348
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics of buspirone analogues interacting with the 5-HT1A and 5-HT2A serotonin receptors.
Bronowska A; Leś A; Chilmonczyk Z; Filipek S; Edvardsen O; Ostensen R; Sylte I
Bioorg Med Chem; 2001 Apr; 9(4):881-95. PubMed ID: 11354671
[TBL] [Abstract][Full Text] [Related]
8. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
Mokrosz MJ; Boksa J; Charakchieva-Minol S; Wesołowska A; Borycz J
Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
[TBL] [Abstract][Full Text] [Related]
9. Theoretical models of interactions between buspirone analogues and 5-HT1A and 5-HT2A serotonin receptor subtypes.
Bronowska A; Sylte I; Edvardsen Ø; Østensen R; Leś A; Chilmonczyk Z
Acta Pol Pharm; 2000 Nov; 57 Suppl():40-5. PubMed ID: 11293260
[TBL] [Abstract][Full Text] [Related]
10. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
Bielenica A; Kozioł AE; Struga M
Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
[TBL] [Abstract][Full Text] [Related]
11. Studies on the neuroendocrine role of serotonin.
Jørgensen HS
Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
[TBL] [Abstract][Full Text] [Related]
12. Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY; Li Z; Kaneda Y; Ichikawa J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
